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ABSTRACT

ATTENTION DEFICIT HYPERACTIVITY DISORDER WITH COMORBID
ANXIETY/DEPRESSION IN ADULTS: IMPACTS ON NEUROPSYCHOLOGICAL
FUNCTIONING
Cristina V. Bain
Virginia Consortium Program in Clinical Psychology, 2018
Director: Dr. Robin J. Lewis
ADHD comorbidity with other disorders is high in the adult population (over 44% of
individuals carry a second diagnosis, 25% anxiety, 18.6% in depression). Separately, these
disorders can impact scores on neuropsychological assessments. Little research has
investigated how comorbidity among ADHD and other disorders impacts test scores
collectively. Given high rates of comorbidity between ADHD and anxiety/depressive
disorders and the potential impact on neuropsychological functioning, the current study
examined how these comorbid disorders collectively impact cognition. Specifically, the
present study investigated differences in full scale intelligence, general ability, and
cognitive proficiency on the WAIS-IV between those diagnosed with ADHD only and those
who also have a comorbid anxiety/depressive disorder. This study also investigated the
impact of these comorbid diagnoses on working memory, processing speed, executive
functioning, and inattention/impulsivity. Specifically, this study tested whether the
relationship between ADHD and these four outcome variables could be predicted by the
presence of a comorbid anxiety/depressive disorder. Results indicated that there were no
significant differences between the two groups for full scale intelligence or general ability.
Across both groups, participants had lower cognitive processing scores when compared to
general ability scores. With regards to the predictive ability of a comorbid diagnosis, only

two of the analyses were significant. The presence of an anxiety or depressive disorder
predicted the relationship between ADHD and working memory and a measure of visual
scanning, sequencing, and psychomotor speed (Trailmaking A). In other words, scores on
these two outcome variables differentiated participants who had a co-occurring anxiety or
depression diagnosis from those with only ADHD. This study addresses a gap that exists in
the current literature by focusing on ADHD comorbid with other disorders, a highly
common occurrence that has been infrequently studied. This study also investigates these
disorders in an adult population, contrasting previous research that focused solely on
children and adolescent populations.
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CHAPTER I
INTRODUCTION
Although the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition,
Text Revision (DSM-IV-TR; American Psychiatric Association, 2000) allowed for the
diagnosis of ADHD in adults, the updated Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition (DSM-5; American Psychiatric Association, 2013) provides clearer
criteria and information on this disorder in adulthood. According to the DSM-V, ADHD
affects approximately 2.5% of the adult population. There is evidence that prevalence rates
may actually be higher, as adults tend to underreport symptoms of ADHD experienced in
childhood (Barkley, Fischer, Smallish, & Fletcher, 2002) making some ineligible for a full
diagnosis due to diagnostic criteria requiring presence of symptoms prior to age 12
(American Psychological Association, 2013). Research has indicated that there is a
significant rate of symptom continuation and impairment well into adulthood (Mitchell,
Nelson-Gray, & Anastopoulos, 2008). Another issue arising with adults suffering from
ADHD is high comorbidity with other disorders, which presents unique challenges to
diagnosis and treatment (Mitchell, Nelson-Gray, & Anastopoulos, 2008). In addition, these
comorbid disorders also contribute to poorer functioning (Wilens, Biederman, & Spencer,
2002). In adults, as many as 25% of adults with ADHD also meet criteria for an anxiety
disorder (Jarrett & Ollendick, 2008) and 18.6% with ADHD meet criteria for a depressive
disorder (Kessler, et al., 2006).
ADHD
Attention Deficit/ Hyperactivity Disorder (ADHD) was historically regarded as a
childhood and adolescent disorder, impacting 3-5% of children (American Psychological
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Association, 1994). More recently, research has conclusively shown that ADHD is a
developmental disorder that, for many, persists over the lifespan (Schmidt & Petermann,
2009). ADHD impacts many areas of functioning, including behavioral, cognitive,
emotional, and neuropsychological (American Psychiatric Association, 1994). The most
commonly associated symptoms of ADHD are related to inattention, impulsivity, and
hyperactivity. These symptoms often lead to difficulties in school, work, social, and family
contexts. According to the DSM-5, diagnosis of ADHD requires a persistent pattern of
inattention and/or hyperactivity and impulsivity that interferes with function and
development. There are specifiers corresponding to the predominant symptoms:
predominantly inattentive presentation, predominantly hyperactive/impulsive
presentation, and combined presentation (American Psychological Association, 2013). See
Table 1 for more information on specific symptoms of ADHD.
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Table 1.
Symptoms of ADHD
Inattention
Fails to pay close attention to details or
makes careless mistakes in schoolwork, at
work, or during other activities

Hyperactivity/Impulsivity
Fidgets with or taps hands or feet or
squirms in seat

Difficulty sustaining attention in tasks or
play activities

Leaves seat in situations when remaining in
seat is expected

Does not seem to listen when spoken to
directly

Runs about or climbs in situations where it
is inappropriate, is restless

Does not follow through on instructions
and fails to finish schoolwork, chores, or
duties in the workplace

Unable to play or engage in leisure
activities quietly

Has difficulty organizing tasks and
activities

Is often “on the go” acting as if “driven by a
motor”

Avoids, dislikes, or is reluctant to engage in Talks excessively
tasks that require sustained mental effort
Loses things necessary for tasks or
activities

Blurts out an answer before a question has
been completed

Is easily distracted by extraneous stimuli

Has difficulty waiting his or her turn

Often forgetful in daily activities

Interrupts or intrudes on others

Note. In addition, several of these symptoms must be present prior to age 12 and be
present in two or more settings. There also should be clear evidence that the symptoms
interfere with individual’s ability to function in social, academic, or occupational settings.
Lastly, six or more symptoms must be present for six months or longer (American
Psychological Association, 2013).
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ADHD in Adulthood
Barkley (1998) found that 50-70% of children who experience ADHD in youth
continue to exhibit signs of the disorder in adulthood. While it is clearly a disorder that
persists well beyond childhood or adolescence, ADHD can present differently in adulthood.
Whereas primary symptoms in childhood and adolescence are often related to
hyperactivity and problems in school, for adults, areas of functioning effected include work
and social relationships/partnerships (Soren & Petermann, 2009). While hyperactivity and
impulsivity remain core symptoms of ADHD in adults, they present as feelings of agitation
or attempts to avoid inactive tasks (Burke and Vorster, 2016). Adults may report feeling
restless or overwhelmed, talk excessively, and choose jobs or tasks that require a lot of
energy (McIntosh et al., 2009). Impulsivity can present in different ways as well. Adults
may shift jobs impulsively, drive too fast, or be quick to anger. Inattention may appear in
adults as difficulty reading or keeping up with paperwork, distractibility, forgetfulness,
poor time management, and difficulty finishing tasks (McIntosh et al., 2009).
Although more attention has been given to this disorder across the lifespan, there is
still difficulty establishing prevalence rates in the adult population. One issue is that ADHD
has been previously viewed as a childhood disorder. Another primary issue is the high
comorbidity rates of ADHD with other disorders in adulthood (Burke & Vorster, 2016).
Adults with ADHD have more lifetime psychopathology, with over 87% reporting
symptoms of another psychiatric disorder (McGough et al., 2005). Further, ADHD has been
found to be associated with greater disruptive behavior, substance use, mood and anxiety
disorders, and an earlier onset of major depressive disorder (McGough et al., 2005).
Although present with a number of other psychiatric diagnoses, ADHD has specifically high
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comorbidity rates with anxiety and depressive disorders. For this reason, the current
study will focus on these disorders co-occurring with ADHD.
Comorbidity with Anxiety/Depression
According to the DSM-5 (American Psychiatric Association, 2013), ADHD
comorbidity with depressive and anxiety related disorders is higher than found in the
general population. Although no causal link has been demonstrated between ADHD,
anxiety, and depressive disorders, it is clear that there is a relation between these areas of
psychological functioning and therefore a need for the ability to assess, intervene, and treat
the comorbid disorders (Soren & Petermann, 2009). One model used to understand ADHD,
executive dysregulation, also offers an explanation of how this disorder would become
highly comorbid with anxiety and/or depression. Executive dysregulation posits that
individuals with ADHD have poor regulatory control of both inhibition and activation
(Brown, 2000). This poor regulation of attention and affect can lead to an increased
attention to negative or harmful stimuli and decreased regulation of the accompanying
emotional response (Brown, 2000; Scahtz & Rostain, 2006).
Much of the research investigating ADHD with comorbid disorders has focused on
child and adolescent populations. In samples of children with ADHD diagnoses, almost
33% also exhibit anxiety related symptoms and up to 52% exhibit depressive symptoms
(Managing ADHD Comorbidity, 2007; Mayes, Calhoun, Chase, Mink, & Stagg, 2008;
McGough et al., 2005). However, there has been a shift towards focusing on the impact of
ADHD with comorbid disorders in adults. Specifically, there is interest in how functioning
is impacted in adults who experience ADHD with another psychiatric diagnosis. Some
researchers posit that these co-occurring disorders and the effects of the comorbidity are
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additive (Geller, Biederman, Faraone, Spencer, Doyle, & Mullin, 2004; King, Waschbusch,
Frankland, Andrade, Thurston, & McNutt, 2005). In other words, instead of simply having
overlapping symptomology or features, the presence of the two disorders produces distinct
effects that happen together. Researchers have identified the need to study the impact of
comorbidity on diagnosis, treatment, and outcome in children as well as adults (Brown
2000; Mayes et al., 2008).
Anxiety. ADHD and anxiety disorders are highly comorbid. In some samples, as
many as 25% of adults with ADHD also meet criteria for an anxiety disorder (Jarrett &
Ollendick, 2008; Schatz & Rostain, 2006). There also appears to be an age-related increase
in prevalence rates of anxiety disorders appearing with ADHD (Managing ADHD
Comorbidity, 2007). In one study of adults who experienced symptoms of ADHD that
persisted from childhood, as many as 40% of men and 50% of women had anxiety
disorders (Biederman, Faraone, Spencer, Wilens, Mick, & Lapey, 1994). These findings
show that the prevalence rate of anxiety disorders is higher for those with ADHD than
those without as prevalence rates based on nationally representative survey data indicate a
lifetime prevalence rate of 28.8% for anxiety disorders and 20.8% for mood disorders
(Kessler, Berglund, Demier, Jin, Merikangas, & Walters, 2005).
Symptoms of anxiety can often mirror and exacerbate those associated with ADHD.
According to the DSM-5, anxiety disorders involve anticipation of a future threat and the
accompanying emotional, behavioral, and physiological symptoms (American Psychological
Association, 2013). Individuals experience excessive and persistent worry that makes it
difficult to maintain control and to concentrate. In addition, individuals likely experience
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the physical symptoms of restlessness, difficulty concentrating, irritability, and sleep
disturbance (American Psychological Association, 2013).
Depression. ADHD and depressive disorders are also highly comorbid. In children,
comorbidity rates are as high as 52% (Mayes et al., 2008). Children who experience both
disorders have also demonstrated greater impairment in social and academic functioning
when compared with controls and those with only ADHD or depression (Blackman,
Ostrander, & Herman, 2005). In a national study of adult ADHD comorbidity, major
depressive disorder had a prevalence rate of 18.6% in adults with ADHD (Kessler, et al.,
2006). This is compared to a prevalence rate of 7.8% in adults without ADHD. Higher rates
of dysthymia were also found. For adults, co-occurring ADHD and depression leads to poor
long-term outcomes, including negative impacts on occupational and social functioning
(McIntosh et al., 2009).
Like anxiety, symptoms of depression can have an increasingly damaging impact
when combined with those of ADHD. According to the DSM-5 (2013), common features of
depression include sad or irritable mood accompanied by somatic and cognitive changes
that impact functioning. Individuals may experience fatigue and sleep disturbance. They
also are likely to experience difficulty concentrating, maintaining focus or concentration,
and difficulty making decisions. These challenges, combined with symptoms of ADHD, can
prove detrimental to many areas of adult life and ability to function effectively (McIntosh et
al., 2009).
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Neuropsychological Impact
ADHD
Some researchers have questioned the utility of neuropsychological assessment in
diagnosing ADHD, particularly, the use of executive function measures. However, research
has consistently shown that some tests differentiate children with ADHD from controls as
detailed below (Pritchard, Nigro, Jacobson, & Mahone, 2012).
Intelligence. While some studies have recently begun to focus on adult ADHD and
intellectual functioning, much of the past research in this domain has involved children.
This is primarily due to the age of onset of ADHD and the historical view of ADHD as a
disorder of childhood and adolescence. Studies have identified that children with ADHD
demonstrate lower overall intelligence quotient (IQ) (Lee et al., 2008), working memory,
and processing speed scores (Hervey, Epstein, & Curry, 2004; Mayes & Calhoun, 2006;
Thaler, Bello, & Etcoff, 2013) when compared to healthy controls. These deficits are
consistently able to differentiate those with ADHD diagnoses from those without.
Studies examining the impact of ADHD on Weschler Adult Intelligence Scale- IV
(WAIS-IV) scores point to consistent deficits. A meta-analytic review by Bridgett and
Walker (2006) found that adults with ADHD have lower WAIS-IV FSIQ scores. The review
found that, on average, adults with ADHD have Full Scale Intelligence Quotient (FSIQ)
scores that are 2.94 points lower than adults without ADHD. This difference motivated
researchers to consider other measures of intelligence, including the General Ability Index
(GAI), a measure of intellectual ability that excludes working memory and processing
speed subtests. Harrison, DeLisle, & Parker (2008) examined the GAI in adults with ADHD
and found significantly higher performance when compared to FSIQ.
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In a review by Seidman (2006) 72% of studies that examined cognitive deficits in
ADHD found impaired performance on the WAIS-IV, with working memory deficits most
prominent. In a 2014 study (Theiling & Petermann), researchers found that adults with
ADHD showed significantly lower scores on subtests involving working memory and
processing speed when compared to adults with no diagnosis. They also compared the GAI
to the FSIQ. Those with ADHD had significantly higher GAI scores when compared to their
FSIQ scores, primarily due to the fact that the GAI offers an estimate of general intellectual
ability with a reduced emphasis on working memory and processing speed. The authors of
this study concluded that the WAIS-IV reliably differentiated between controls and
individuals with ADHD and that deficits in those with ADHD were robust and consistent.
Lastly, this study provided evidence for consideration of the GAI in patients with ADHD as
it may allow for a better understanding of current intellectual functioning in individuals
with ADHD.
As a whole, the adult ADHD literature involving WAIS-IV scores demonstrates that
this assessment tool clearly discriminates between healthy controls and adults with ADHD.
The identification of strengths and weaknesses through this measure is important as it can
be useful to facilitate successful intervention (Woods, Lovejoy, & Ball, 2002).
Attention/Impulsivity. Two hallmark symptoms of ADHD include
inattention and impulsivity. A type of measure called a continuous performance test has
been utilized widely in the assessment and diagnosis of ADHD to assess for deficits in these
functioning areas. The continuous performance test is a vigilance task used to study
sustained attention and also to assess for any deficits (Ballard, 2001). These tasks typically
require individuals to perform a mundane task that requires sustained attention and
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inhibition of impulsive responses. On the Gordon Diagnostic System (GDS), which is a
continuous performance task used to assess attention deficits and executive functioning
skills (i.e. vigilance), children with inattentive symptoms of ADHD had impaired scores
related to those without.
In a separate study comparing the scores of adults with ADHD with healthy controls,
White, Hutchens, and Lubar (2005) found that those with ADHD demonstrated more
impaired performance on the IVA CPT, a continuous performance test used to assess both
adults and children. Another similar task, the Conner’s Continuous Performance Test, has
repeatedly been shown to differentiate ADHD from normal or control groups (Epstein,
Erkanli, Conners, Klaric, Costello, & Angold, 2003). In a sample of 817 children, the
Conner’s CPT consistently differentiated between those with ADHD diagnoses and those
without. Children with ADHD consistently made more errors of commission and omission.
They also demonstrated more variable reaction times.
Executive Functioning. Executive functioning (EF) is a term used to encompass
various complex cognitive processes and sub-processes (Elliot, 2003). Broadly, it refers to
the ability to manage cognitive functioning and is defined somewhat differently by various
researchers/theories. It is comprised of several different skill areas or domains, including
organization/problem solving, time management, emotion regulation, restraint,
motivation, set-shifting, activation, working memory, and inhibition (Jarratt, 2015; Stuss &
Levine, 2002). EF involves the coordination of various processes, like those listed, to reach
a goal in a flexible manner (Funahashi, 2001). When EF systems break down, behavior can
become disinhibited and poorly controlled. The coordination of these processes and their
cohesive contribution toward a goal are key in understanding the concept of EF.
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In a study of 421 college students with a mean age of 18.83, Jarratt (2015) examined
ADHD symptoms in relation to EF. Approximately 10% of the sample was taking
medication to address their ADHD symptoms at the time of the study. Participants
completed self-report measures of ADHD symptomology, anxiety related symptoms, and
executive dysfunction. Overall, inattention was found to be strongly related to deficits in
executive functioning (Jarratt, 2015). Specifically, inattention was related to deficits in selfmotivation, self-organization and problem solving, and emotional control.
Hyperactivity/impulsivity was also related to deficits in executive functioning, although to
a lesser extent.
These deficits are also found in studies involving children and adolescents.
Chhabildas, Pennington, & Willcutt, (2001) found that children with inattention issues
related to ADHD displayed impaired processing speed on the Wechsler Intelligence Scale
for Children. On the Trails assessment, a measure of executive functioning, children with
inattentive ADHD had higher total completion times, suggesting impairment in EF domains
such as cognitive flexibility and vigilance. A separate study of children with ADHD found
that those with and without hyperactive symptoms performed poorly on the STROOP test
compared to controls. In particular, the clinical groups demonstrated deficits on
interference portions of the test (Barkley, Grodizinsky, & DuPaul, 1992). Overall, executive
functioning measures have consistently been used with those with ADHD and have offered
interesting findings on specific deficits. Research suggests that using neuropsychological
test batteries, rather than individual measures, offers a more sensitive and specific
approach to diagnosis of ADHD (Pritchard, Nigro, Jacobson, & Mahone, 2011).
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Depression and Anxiety
Intelligence. Depression and anxiety have been found to impact intellectual testing
in several ways. One study (Hill, Smitherman, Pella, O’Jile, & Gouvier, 2008), which
examined the impact of self-reported depression and anxiety on the third edition of the
WAIS (WAIS-III), found that scores on the Working Memory and Processing Speed indices
successfully differentiated between those with symptoms and healthy controls. Deficits in
these two areas of the WAIS were more significant for individuals who reported depressive
symptoms. A significant weakness of this study was that depressive and anxiety symptoms
were self-reported, and no diagnosis was necessary for inclusion in the clinical subgroups.
This finding was, however, consistent with other research indicating deficits in working
memory on neuropsychological testing for those with DSM diagnosed depressive
symptoms (Castaneda et al., 2008). A more recent study (File, 2013) examining working
memory differences between healthy controls and depressed individuals found that
performance deficits were present on all Working Memory Index subtests for those who
reported depressive symptoms. A 2010 review (Marzatti, Consoli, Picchetti, Carlini, &
Faracelli, 2010) of cognitive impairment in major depression also highlighted consistent
deficits in full scale IQ scores for depressed individuals, primarily due to deficits in working
memory and attention.
In a study (Butters et al., 2011) focusing on individuals with Generalized Anxiety
disorder (GAD), deficits were also demonstrated between clinical group functioning and
healthy controls. Utilizing the WAIS-III as part of a testing battery to examine working
memory and processing speed, participants with a diagnosis of GAD performed poorly and
significantly worse than those without GAD. The authors concluded that GAD is associated
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with neuropsychological impairments and that further research should investigate how
other anxiety disorders and related symptoms impact functioning.
Attention/Impulsivity. Deficits in attention and impulsive behavior/thinking can
have numerous causes. In addition to ADHD, depression and anxiety have been found to
impact these areas of functioning (White, Hutchens, & Lubar, 2005). Continuous
performance tests have consistently shown that individuals with anxiety and depression
demonstrate deficits in areas attention and impulsivity. In a study comparing performance
among depressed individuals (n= 33) to healthy controls (n=33), researchers found that
those with depression performed significantly worse on the Continuous Performance TestIdentical Pairs (CPT-IP; Mohn & Rund, 2016). This task requires participants to respond
only when two identical stimuli appear during rapidly flashing trials of numerical strings.
There was a strong correlation between severity of depressive symptoms and scores on the
continuous performance test, with those with more severe symptoms demonstrating larger
deficits.
Similar deficits have been found among individuals with anxiety disorders. Ballard
(2001) reviewed continuous performance test literature and concluded that those with
diagnoses of ADHD, anxiety, depression, and PTSD all demonstrated significantly impaired
performance on these measures. Another study examined continuous performance test
results among children with anxiety (n= 158). Utilizing the Conner’s CPT, researchers
found that those with cognitive anxiety, characterized by worrying and oversensitivity,
performed more poorly on this measure when compared to those without anxiety (Epstein,
Goldberg, Conners, & March, 1997). This finding was especially true for male children.
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Executive Functioning. Executive dysfunction appears to be a key factor in
individuals with depressive disorders (Castaneda et al., 2008) regardless of age (Marazziti
et al., 2010). In a review of research (Castaneda et al., 2008) involving young adults with
depressive disorders in inpatient and outpatient settings, researchers concluded that the
majority of studies found deficits in most areas of executive functioning compared to
healthy controls. Measures of EF that showed impairment for depressed individuals
include the Trail Making Test (TMT), Controlled Oral Word Association Test (COWA), and
the Wisconsin Card Sorting Task (WCST; Castaneda et al., 2008).
In a comprehensive population based study of cognitive functioning in adults with
depressive disorders, Airaksinen and colleagues (2004) used the Trail Making Test and a
measure of verbal fluency, among other tests. Their large sample consisted of adults aged
20 to 64 years with MDD (n = 68), dysthymia (n = 28), mixed anxiety-depressive disorder
(n = 25), minor depression (n = 66), and a group of healthy control participants (n = 175).
Overall, the researchers found that depressed individuals as a whole were impaired on a
measure of mental flexibility (Trail Making Test Part B), but perceptual motor speed (Trail
Making Test Part A) and verbal fluency were not affected by depression. Additionally,
individuals with minor depression did not have significantly impaired scores.
Lastly, in a study comparing 30 depressive out-patient participants to 38 healthy
controls (Den Hartog, Derix, Van Bemmel, Kremer, & Jolles, 2003), depressed individuals
demonstrated cognitive deficits in the automatic processing of words and colors on the
Stroop Color Word Test compared to healthy controls. The authors concluded that
individuals with depression had impairment in efficient information processing.
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Similar deficits in executive functioning have been found in young adults with
anxiety and, more specifically, panic and obsessive compulsive disorders (OCD; Boldrini et
al., 2005). In a sample of 55 adults (25 with OCD, 15 with panic disorder, and 15 healthy
controls), those with OCD demonstrated significant deficits on EF measures including the
COWA. The authors concluded that this suggested deficits in the EF domains of cognitive
flexibility and verbal fluency. However, researchers (Airaksinen, Larsson, & Forsell, 2005;
Castaneda et al., 2008) argued that more research is needed on various subtypes of anxiety
as most previous work has focused on trauma related anxiety and obsessive compulsive
disorders.
Jarratt (2015) found that executive functioning deficits, as measured by self-report
questionnaires, were significantly related to anxiety symptoms. Deficits were
demonstrated across executive functioning domains, including time management, problemsolving, restraint, and emotional regulation. Similar results were found by Airaksinen and
colleagues (2005) who found that anxiety related symptoms were associated with
significant impairments in executive functioning. In this study, a sample of 112 individuals
who met DSM-IV criteria for an anxiety disorder were administered EF measures. These
scores were then compared to the performance of a control group of 175 people with no
current psychiatric disorder or history of mental illness. On the Trail Making Task, there
were no significant differences in psychomotor speed (Part A) between those with anxiety
disorders and those without. Overall, those with anxiety disorders needed significantly
more time to complete Part B, a complex set-shifting task than control participants. More
specifically, individuals with panic disorder and OCD were slower than controls, while
individuals diagnosed with specific phobia, social phobia, or generalized anxiety disorder
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(GAD) were not. However, further analyses suggested this impairment may have been
related to alcohol use. Individuals taking medication for anxiety were slower to complete
Trail Making Test Part B than individuals with anxiety, but not taking medication and
control participants; the latter two groups were not significantly different. They also found
impairment in verbal fluency among those with social phobia, while individuals with panic
disorder, specific phobias, and GAD were not significantly different from control
participants. The authors concluded that this suggests obvious deficits in psychomotor
speed and verbal fluency in individuals with anxiety disorders (Airaksinen et al., 2005).
Lastly, previous research has suggested that anxiety impacts executive functioning
by interfering with cognitive processing (Eysenck, Derakshan, Santos, & Calvo, 2007).
Anxiety impacts efficient functioning of individuals’ goal directed attentional system. By
decreasing attentional control, anxiety has adverse impacts on the EF domains of inhibition
and set shifting.
Comorbid ADHD and Depression/Anxiety
There is a paucity of research investigating how disorders comorbid with ADHD
impact neuropsychological test performance. Some of the research investigating
comorbidity between ADHD and depression/anxiety disorders involves children and
adolescents. Tannock, Ickowicz, and Schachar (1995) investigated the impact of ADHD
medication on working memory functioning in children with anxiety and ADHD. When
compared to children with only an ADHD diagnosis, the comorbid group had significantly
lower scores on measures of working memory. After introducing stimulant medication,
working memory improved in the nonanxious ADHD group but not in the comorbid group.
The researchers suggested that these findings indicated that ADHD comorbid groups
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constitute a distinct subtype of those with ADHD and that further research should
investigate the neuropsychological impacts of these co-occurring disorders (Tannock,
Ickowicz, & Schachar, 1995).
One study investigated the relationship between ADHD and anxiety related
symptoms in emerging adults (Jarrett, 2015). In a sample of 421 college students, ranging
in age from 17-21, researchers assessed executive functioning, via self-report, in those with
ADHD, those with anxiety, and those with comorbid ADHD and anxiety. Results indicated
that executive functioning skills were more significantly impaired in participants with
comorbid disorders. Further, those with ADHD and anxiety demonstrated increased
difficulties with self-regulation, self-organization, and problem solving. These difficulties
fall in the domains of executive functioning and working memory. The researcher
indicated the need for further assessment of these comorbid disorders in adults to allow
for better understanding of deficits and a more tailored approach to intervention.
The Current Study and Hypotheses
The purpose of the present study is to enhance understanding of how comorbid
ADHD and depression/anxiety disorders impact neuropsychological functioning.
Specifically, the present study investigates differences in full scale intelligence, general
ability, and cognitive proficiency on the WAIS-IV between those diagnosed with ADHD only
and those who also have a comorbid anxiety/depressive disorder. This study also
investigates the relationship between comorbid diagnoses and working memory,
processing speed, executive functioning, and inattention/impulsivity. Specifically, this
study tests the effects of working memory, processing speed, executive functioning, and
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inattention/impulsivity on the likelihood that participants have a comorbid anxiety or
depression disorder.
This research contributes to the literature by examining how comorbid ADHD and
anxiety/depressive disorders impact cognitive functioning in an adult population. This
study addresses a gap in the literature by focusing on ADHD comorbid with other
disorders, an occurrence with a high prevalence rate but one that has been infrequently
studied. This study also investigates these disorders in an adult population, contrasting
previous research that focused solely on child or adolescent populations.
Fostering a better understanding of the relationship between these disorders,
specifically when comorbid, can inform clinical interventions as well as future research
endeavors. Based on the rationale featured above, this study will investigated differences
between those with ADHD only and ADHD with a comorbid depressive/anxiety disorder in
areas of cognitive ability, including full scale IQ, general ability, and cognitive proficiency.
The study also tested whether the presence of a comorbid anxiety or depression disorder
could be predicted from participant’s scores on measures of working memory, processing
speed, executive functioning, and inattention/impulsivity. The following hypotheses were
be tested:
-

H1. Adults with a comorbid anxiety/depressive disorder will have lower FSIQ and
GAI when compared with those who have ADHD only.

-

H2. Adults in both groups (adults with ADHD comorbid and ADHD only) will
demonstrate lower CPI scores when compared to the GAI scores (H2.a.). CPI will be
lower in the ADHD comorbid group when compared to the ADHD only group (H2.b.).
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-

H3. Test scores on measures assessing working memory (H3.a.), processing speed
(H3.b.), executive functioning (H3.c.), and attention/impulsivity (H3.d.) will predict
the presence of a comorbid anxiety or depression disorder.
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CHAPTER II
METHOD
Participants
Data was accumulated from archival testing records from the neuropsychology
clinic at a large academic medical center in the mid-Atlantic United States. All participants
are adults referred for neuropsychological testing to further evaluate for the presence of an
attention related disorder. Only participants over the age of 18 and without any comorbid
cognitive disorder were considered for this study. Testing occurred between 2007 and
2016. Data available for each participant was drawn from the intake history form, initial
intake session, neuropsychological testing scores, and the final report. This study utilizing
this testing data was approved by the committee on human subjects research prior to data
extraction and analysis. The study participants were divided into two groups, those with
ADHD only and those with ADHD and a comorbid anxiety/depressive disorder. Groups
were divided based on the clinician’s diagnosis, which is based on the clinical interview,
patient history, behavioral observation, and test scores. Additional measures used in
diagnosing ADHD included the Wender Utah Rating Scales (WURS; (Ward, Wender, &
Reimherr, 1993) and Conners Adult ADHD Rating Scale-Self Report: Long Version (CAARSS:L; Conners, Erhardt, & Sparrow, 1999). Measures used to diagnose anxiety and
depression related symptoms include the Beck Anxiety Inventory (BAI; Beck & Steer, 1993)
and the Beck Depression Inventory Second Edition (BDI-II; Beck, Brown, & Steer, 1996).
To evaluate the minimum sample size needed for this study power analyses were
conducted. Using G*Power, a power analysis for the ANOVA was completed (Faul,
Erdfelder, Buchner, & Lang 2009). This analysis was used to compare differences between
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those with ADHD only and those with ADHD and a comorbid anxiety/depressive disorder
on several neuropsychological assessments. With an α of .05, a sample size of 208
participants achieves a power of .95. With an α of .05, a sample size of 128 participants
achieves a power of .8.
To test the third hypothesis, binary logistic regression was utilized. Using G*Power,
a power analysis for an a priori logistic analysis was calculated. With an α of .05, a sample
size of 145 participants achieves a power of .95.
A total of 141 participants were included in the study based on the previously
discussed inclusion criteria. Data were then examined for missing values. Due to the
analyses to be utilized, cases were only excluded if scores necessary for hypotheses
proposed were missing. In total, 12 participants were excluded due to missing data
bringing the sample to 129.
Demographics. Demographic variables of participants are displayed in Table 1.
Participants’ ages ranged from 18 to 67, with a mean age of 32.76 years. The sample was
predominantly Caucasian (76.7%) and African American (17%) with the remainder
identifying as Hispanic (7%) and Asian (6%). The sample was almost evenly split among
male (45.7%) and female (54.3%) participants. Education level varied from 7 years to 20
years, with an overall average of 13.82. The majority of participants were single (58.1%),
with the rest either married (34.9%) or divorced (7%). Of the 129 participants, 56 were on
a psychoactive medication at the time of testing. Of those, 29 (52%) were on medication to
treat anxiety or depression symptoms, 21 (38%) were on medication to treat ADHD
symptoms, 5 (9%) were on medication for pain, and 1 (1%) was on a sleep medication. In
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total, 80 participants carried a comorbid anxiety or depression diagnosis while 49 only
received an ADHD diagnosis.
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Table 2
Demographic Variables of Participants
Variable

N
Percentage

Gender
Male

59

45.7

Female

70

54.3

Caucasian

99

76.7

African American

17

13.2

Hispanic

7

5.4

Asian

6

4.7

Single

75

58.1

Married

45

34.9

Divorced

9

7

Ethnicity

Marital Status
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Measures
Demographic Information. Participants were asked to report demographic
information on the intake form and during the initial interview. Information gathered
includes age, race, ethnicity, gender, marital status, current medication use, and highest
education level attained.
Premorbid Functioning. In order to estimate cognitive abilities, the Test of
Premorbid Functioning (TOPF) was used (Psychological Corporation, 2009). This
assessment is a revised version of the Wechsler Test of Adult Reading (WTAR; Wechsler,
2001) and provides an estimate of an individual’s premorbid cognitive and memory
functioning. The TOPF is based on a reading paradigm (Psychological Corporation, 2009).
It requires participants to read and pronounce words that have unusual or irregular
grapheme to phoneme transitions (Psychological Corporation, 2009). The total score is the
number of words correctly pronounced. An estimated WAIS-IV FSIQ is obtained based on
demographic information and test score.
Intellectual Functioning. Intellectual functioning was assessed using the Wechsler
Adult Intelligence Scale- Fourth Edition (WAIS-IV; Wechsler, 2008). The WAIS-IV provides
several different scales that measure different areas of intellectual ability. General
intellectual functioning is expressed in a Full Scale Intelligence Quotient (FSIQ), with four
specific cognitive areas represented by separate index scores: Verbal Comprehension Index
(VCI), Perceptual Reasoning Index (PRI), Working Memory Index (WMI), and Processing
Speed Index (PSI; M=100, SD=15). All index scores contribute to the FSIQ. Several subtests
(M=10, SD=3) then make up each index score. In this study, two other index scores will be
utilized. One is the General Ability Index (GAI), which measures general mental ability
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(Wechsler, 2008). This index is derived from the core VCI and PRI subtests. It is useful as it
provides a measure of general mental ability with a reduced emphasis on working memory
and processing speed (relative to the FSIQ). In contrast, the Cognitive Proficiency Index
(CPI), as developed on the Wechsler Intelligence Scale for Children-Fourth Edition
(Wechsler, 2014), will be derived from WMI and PSI subtests (Wechsler, 2008). This index
represents an individual’s proficiency at cognitive processing. This study will use the FSIQ,
GAI, and CPI.
Executive Functioning. Several measures were used to assess executive
functioning. The Controlled Oral Word Association test (COWA; Benton, 1969) measures
both verbal fluency and executive functioning. In this task individuals are given one minute
to spontaneously generate words that begin with a certain letter for three trials. Testretest reliability for this assessment falls between .70 and .88 (Spreen & Straus, 1998).
Internal consistency was also high (α =.83; Ruff, Light, Parker, & Levin, 1996). For the
current study the internal consistency was α =.77. The total score is the number of words
generated across all trials.
The Stroop Neuropsychological Screening Test (SNST; Trennery, Crosson, DeBoe, &
Leber, 1988) measures response inhibition and selective attention. During the Color Task,
the individual reads aloud a list of color names as quickly and accurately as possible. In the
Color-Word Task, the individual names the color of the ink in which the color names are
printed, which is not congruent with the printed word, as quickly and accurately as
possible. Test-retest reliability is strong (α= .90) for this measure. The score used was the
total score for the Color-Word Task.
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The Trail Making Test (Army Individual Test Battery, 1944) measures executive
functioning domains of cognitive flexibility, divided attention, and visual tracking (Reitan,
1992). The task consists of two parts, A and B, with each part timed by the test
administrator. In part A, individuals are tasked with connecting numbered dots in
numerical order. In part B, the task is slightly more complex and requires individuals to
connect dots alternating between letters and numbers (i.e. 1-a, 2-b, 3-c; Retain, 1992).
Reliability coefficients for both tasks A and B fall between .60 and .90 (Spreen & Straus,
1998). The Trail Making Test also demonstrates strong interrater reliability (Trails A= .94,
Trails B= .90; Fals-Stewart, 1992). The scores used were T scores based on the individual’s
total time to complete each part.
Attention/Impulsivity. The Integrated Visual and Auditory Continuous
Performance Test (IVA+Plus; Sanford & Turner, 2004) was developed to assess sustained
attention and impulsivity via a mundane automated task (Sanford & Turner, 2004; Arble,
Kuentzel, & Barnett, 2014). The task requires participants to monitor information
presented both visually and auditory. They are tasked with responding to predetermined
target stimuli while at the same time refraining from responding to distractor stimuli
(Arble, Kuentzel, & Barnett, 2014). The measure provides scores for inattention and
impulsivity for both visual and auditory attention (Sanford & Turner, 2004). The IVA +
Plus continuous performance task has strong empirical support for its clinical sensitivity
and validity in measuring attentional functioning (Tinius, 2003; White, Hutchins, & Lubar,
2005).
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CHAPTER III
RESULTS
Preliminary Analyses

Preliminary analyses assessed for missing data, outliers, coding errors, and
assumptions of statistical analyses. Individuals who were missing necessary data points
were removed from analyses, with 12 cases removed. See table 3 for average scores for
measures.

An initial cross tabulation analysis was computed to determine if there was a
difference between the groups based on level of education attained, current medication
use, and estimated full scale intelligence quotient. There were no outliers in the data
utilized for this analysis, as assessed by inspection of a boxplot. Variables were normally
distributed across both ADHD and ADHD comorbid groups, as assed by Shapiro-Wilks’ test
(p>.05). There was homogeneity of variances for highest education level (p=.966),
medication use (p=.786), and estimated full scale IQ (p=.171) for both ADHD and ADHD
comorbid groups, as assessed by Levene’s test for equality of variances. There were no
significant differences between groups based on education level or estimated full scale IQ.
There was a statistically significant difference in medication use among ADHD only and
ADHD comorbid groups, X2(1,129)=7.25, p< .05). Due to this difference between groups,
medication use was used as a covariate in statistical analyses.
Hypothesis One
We hypothesized that there would be significant differences between groups based
on both FSIQ (H1a) and GAI (H12), with the ADHD comorbid group having lower scores on
Table 3
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Average Scores for Test Measures

Variable

ADHD Only
(n = 49)

ADHD with
Comorbid
Disorder
(n = 80)

Total
(N = 129)

Intellectual Ability
FSIQ

102.04 (13.61)

100.68 (14.59)

101.19 (14.19)

GAI

103.43 (14.95)

105.41 (16.05)

104.66 (15.61)

CPI

97.96 12.35)

94.85 (11.89)

96.03 (12.12)

PSI

96.82 (12.47)

95.15 (13.24)

95.78 (12.9)

WMI

100.22 (12.59)

94.44 (14.25)

96.64 (13.89)

COWAT

46.36 (9.38)

44.08 (10.13)

44.94 (9.88)

SNST

95.67 (19.13)

88.94 (20.66)

91.50 (20.82)

Trailmaking A

47.57 (10.39)

43.89 (10.25)

45.29 (10.42)

Trailmaking B

48.41 (11.57)

46.41 (10.39)

47.17 10.86)

IVA FSRCQ

75.87 (24.11)

73.59 (22.82)

74.50 (23.22)

IVA FSAQ

57.77 (30.01)

60.09 (31.97)

59.15 (31.13)

Executive Functioning

Attention/ Impulsivity

Note: Intellectual ability and Attention/Impulsivity scores are standard scores with a
mean=100, SD=15. The COWAT and Trailmaking tests utilize T scores with a mean=50,
SD=10. SNST scores are raw scores for time. Standard deviations presented following each
value in parenthesis.
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both indices when compared to the ADHD only group. In order to evaluate the first
hypothesis regarding the differences between the two groups (ADHD only and ADHD
comorbid) an analysis of covariance (ANCOVA) was conducted. Assumptions were tested
prior to analysis. There was a linear relationship between variables across both groups, as
assessed by visual inspection of a scatterplot. There was homogeneity of regression slopes
as the interaction term was not statistically significant, F(1,125)= .131, p= .718.
Standardized residuals were normally distributed, as assessed by Shapiro-Wilk’s test
(p>.05). There was homoscedasticity, as assessed by visual inspection of the standardized
residuals plotted against the predicted values. There was homogeneity of variances, as
assessed by Levene’s test of homogeneity of variance (p= .765).
There was one outlier for FSIQ, and this value was Winsorized (Wilcox, 2005) to the
next highest value on the scale. For the ANCOVA, the grouping variable was based on
diagnosis (ADHD only and ADHD comorbid). The dependent variables were FSIQ (H1a)
and GAI (H1b). Current medication use was included as a covariate. There was no
significant difference in FSIQ scores between the two groups, F(1,126)=.673, p= .413,
partial η 2=.005. There was also no significant difference in GAI scores between the two
groups F(1,125)=.303, p= .583, partial η 2=.009.
Hypothesis Two
Hypothesis two posited that across both groups, ADHD only and ADHD comorbid,
participants would have lower Cognitive Proficiency Index (CPI) scores when compared to
their General Ability Index (GAI) scores (H2.a.). It was also hypothesized that the ADHD
comorbid group would have lower CPI scores when compared to the ADHD only group
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(H2.b.). To test these hypotheses a one sample T-test and Analysis of Covariance were
utilized.
The first part of hypothesis two (H2.a.) was addressed using a one sample T test.
Prior to data analyses assumptions were tested. The test scores (CPI and GAI) represent
independent scores and variables are appropriate for this analysis. No significant outliers
were detected as assessed by inspection of a boxplot. CPI and GAI scores were normally
distributed, as assessed by Shapiro-Wilk’s test (p> .05). As predicted, CPI was significantly
lower than GAI scores, t(128)= 89, p< .001. Across both groups the average CPI score was
96.03, while the average GAI score was 104.66.
To test the second part of the hypothesis (H2.b) we utilized an Analysis of
Covariance. Assumptions were tested before data analysis. The independent variable of
group membership is categorical and the two groups were independent of each other. Test
observations were also independent. There was a linear relationship between the
covariate (medication use) and CPI scores as assessed by a visual inspection of a
scatterplot. There was homogeneity of regression slopes as the interaction term was not
statistically significant, F(1, 125)= 1.39, p= .241. Standardized residuals for the groups
were normally distributed, as assessed by Shapiro-Wilk’s test (p> .05). There was
homoscedasticity, as assessed by visual inspection of the standardized residuals plotted
against the predicted values. There was homogeneity of variances, as assessed by Levene’s
test of homogeneity of variance (p= .662). No outliers were detected. After adjustment for
medication use, there was not a statistically significant difference in CPI scores between the
ADHD only and ADHD comorbid groups, F(1,126)= 2.337, p= .129, partial η2 = .018.
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Hypothesis Three
Lastly, it was hypothesized that test scores measuring several different areas
(working memory, processing speed, executive functioning, and attention/impulsivity)
would predict the presence of a comorbid anxiety or depression disorder. To test all parts
of this hypothesis (H3.a., H3.b., H3.c., H3.d.), binary logistic regression was utilized. This
analysis tested the relationship between ADHD diagnosis, presence of a comorbid
anxiety/depressive disorder, and predictor variables. Outcome, or dependent, variables
included in this analysis included group membership, either to the ADHD only group or the
ADHD comorbid group. Predictor variables include working memory (H3.a.), processing
speed (H3.b.), executive functioning (H3.c.), and inattention/impulsivity (H3.d.)
Prior to analyses assumptions were tested. Linearity of the continuous variables
with respect to the logit of the dependent variable was assessed via the Box-Tidwell (1962)
procedure. A Bonferroni correction was applied using all fifteen terms in the model
resulting in statistical significance being accepted when p < .00333 (Tabachnick & Fidell,
2007). Based on this assessment, all continuous independent variables were found to be
linearly related to the logit of the dependent variable. The logistic regression model was
statistically significant, χ2(14) = 24.502, p < .05. Nagelkerke equals 26.7% of the variance
in diagnoses and correctly classified 64.9% of cases. Sensitivity was 46.7%, specificity was
77.3%, positive predictive value was 58.3% and negative predictive value was 68%. Of the
six predictor variables only two were statistically significant: Working Memory Index and
Trailmaking A (as shown in Table 2). Individuals with lower Working Memory Index
scores were 14.64 times more likely to feature an anxiety or depression diagnosis than
those with higher scores. Lower Trailmaking A scores, a measure of executive functioning,
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was associated with an increased likelihood of an anxiety or depression diagnosis in
addition to ADHD.
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Table 4
Logistic Regression Predicting Likelihood of Comorbid Anxiety/Depression Diagnosis based on
Working Memory, Processing Speed, and Executive Functioning
95% CI for Odds
Variables
B
SE
Wal
Df
p
Odds
Ratio
d
Ratio
Lower Upper
WMI

.035

.018

3.93

1

.047*

1.04

1.00

1.07

PSI

-.025

.020

1.57

1

.210

.975

.938

1.01

COWA

.003

.021

.025

1

.874

1.00

.963

1.05

TrailA

.047

.023

4.06

1

.044*

1.05

1.00

1.09

TrailB

-.025

.024

1.08

1

.299

.976

.931

1.02

Stroop

.017

.012

2.03

1

.154

1.02

.994

1.04

-4.206

1.82

5.35

1

.02

.015

Constant

Note: * p < .05.
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CHAPTER IV
DISCUSSION
This study tested differences in several areas of neuropsychological test scores
between those diagnosed with ADHD only and those diagnosed with ADHD and a comorbid
anxiety or depressive disorder. With regards to intellectual ability, this study examined
scores for full scale intelligence, general ability, and cognitive proficiency. Hypotheses
predicted lower full scale intelligence and general ability scores for those with ADHD and a
comorbid anxiety or depressive disorder compared to those with ADHD alone. It was also
hypothesized that cognitive processing scores would be lower than general ability scores
for both groups, with a greater difference between the two for those with a comorbid
disorder. Working memory, processing speed, executive functioning, and
inattention/impulsivity scores were also examined. This study examined whether the
relationship between ADHD and the scores in these domains was differentiated by the
presence of a comorbid anxiety or depressive disorder. Hypotheses predicted that scores
on measures assessing working memory, processing speed, and executive functioning
would predict the presence of a comorbid anxiety or depressive disorder. Specific findings
will be presented for each set of outcome variables. A general discussion of overall
findings, limitations, and future directions for research follows.
FSIQ and GAI
In contrast to the hypotheses, the present study provides no evidence for difference
in full scale intelligence and general ability between those with ADHD only and those with a
comorbid anxiety or depressive disorder. As this is the first known study to explore the
differences between these scores in individuals with ADHD and a comorbid disorder, these
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results, while not supportive of the first hypothesis, represent a novel contribution to the
understanding of how a comorbid disorder may or may not impact different areas of
cognitive functioning and intellectual ability.
CPI and GAI
Results demonstrated that across both groups cognitive processing scores were
significantly lower than general ability scores. This is consistent with the findings of other
studies (e.g., Harrison, DeLisle, & Parker, 2008) which found that cognitive processing
scores for those with ADHD were significantly lower than general ability scores, the latter
of which places less focus on tasks involving working memory and processing speed.
Results did not support the second part of the hypothesis. No difference was found
between cognitive processing scores for the ADHD only and ADHD comorbid group.
Contrary to what was hypothesized, the addition of a comorbid disorder was not associated
with significantly lower cognitive processing scores.
Working Memory
Consistent with hypotheses, working memory scores predicted group membership,
either ADHD only or ADHD comorbid. Lower working memory scores were associated with
a significant likelihood of the individual having a comorbid anxiety or depressive disorder.
Although deficits in working memory for those with ADHD is widely supported by
research, the additional impacts of a comorbid anxiety or depression disorder have not
been examined in adults. The results found in the present study are consistent with similar
findings of more significant deficits in working memory ability in children with ADHD and
anxiety (Tannock, Ickowicz, and Schachar, 1995). These findings add to the understanding
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of how the collective impact of ADHD and a co-occurring anxiety or depressive disorder can
impact an individual’s functional ability.
Processing Speed
No significant effects were found for processing speed. Processing speed scores did
not significantly predict whether or not an individual had a comorbid anxiety or depressive
disorder. Previous research has shown that ADHD (e.g., Thaler, Bello, & Etcoff, 2013),
anxiety (e.g., Butters et al., 2011), and depression (e.g. Hill et al., 2008) all independently
are associated with impaired processing speed. However, this study was the first to look at
the potential combined impact of ADHD and a comorbid anxiety or depressive disorder on
processing speed. Results indicated that there was no significant difference in deficits
observed in those with only an ADHD diagnosis and those with co-occurring anxiety or
depression.
Executive Functioning
To assess executive functioning skills several measures were utilized, including the
Controlled Oral Word Association Test (COWA), Stroop Neuropsychological Screening Test
(SNST), and Trailmaking Tests A and B (TMT). Of these measures, only Trailmaking A
significantly predicted whether a participant had a comorbid anxiety or depressive
disorder. Trailmaking A measures visual scanning, sequencing, and psychomotor speed.
Trailmaking B adds a component of set switching. This finding is in contrast to a previous
study that found that depressed individuals performed more poorly on Trailmaking B
(Airaksinen et al., 2004). The present study provides a unique and novel finding that
shows that Trailmaking A is a tool that can successfully differentiate between individuals
with ADHD only and those with a comorbid anxiety or depressive disorder.
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Attention/Impulsivity
Similar to processing speed, no significant effects were found for
attention/impulsivity. Research has shown deficits in attention/impulsivity for individuals
with ADHD (e.g., White, Hutchins, & Lubar, 2005) and for individuals with anxiety (e.g.,
Ballard, 2001) or depression (e.g., Mohn & Rund, 2016). However, the results of the
present study indicated that there were no significant differences in deficits observed in
those with only an ADHD diagnosis and those with co-occurring anxiety or depression.
In conclusion, there were no significant differences between the two groups for full
scale intelligence or general ability. Across both groups, as expected, participants had
lower cognitive processing scores when compared to general ability scores. With regards
to the predictive ability of a comorbid diagnosis, only two of the analyses were significant.
The presence of an anxiety or depressive disorder predicted the relationship between
ADHD and working memory and a measure of visual scanning, sequencing, and
psychomotor speed (Trailmaking A). In other words, scores on these two outcome
variables differentiated participants who had a co-occurring anxiety or depression
diagnosis from those with only ADHD.
Strengths of the Current Study
This study investigated differences in full scale intelligence, general ability, and
cognitive proficiency on the WAIS-IV between those diagnosed with ADHD only and those
who also had a comorbid anxiety/depressive disorder. This study also examined the
impact of these comorbid diagnoses on working memory, processing speed, executive
functioning, and inattention/impulsivity. Though a growing body of literature examined
the neuropsychological impacts of co-occurring disorders, this study was among the few to
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explore these variables in a sample of adults with ADHD and comorbid anxiety or
depressive disorders to inform whether insights from clinically-based research can be
translated to useful information to aid in the assessment, diagnosis, and understanding of
these frequently co-occurring disorders. Given the high occurrence of comorbidity
between these disorders, it is critical that they are studied in terms of their combined
impact on an individual’s functioning. While the body of research provides a solid
understanding of the ways ADHD, anxiety, and depression can impact functioning in a
number of ways, there is less scientific investigation into how these disorders intersect to
create new and potentially greater challenges for the individual.
Specifically examining the impact of these disorders in an adult population is
another strength of the current study. ADHD has traditionally been viewed as a
developmental disorder impacting children and adolescents, with many of the commonly
viewed consequences related to school performance. However, research has indicated that
for most this disorder persists over the lifetime (Schmidt & Petermann, 2009). Difficulties
related to the symptoms of ADHD are present in work, social, and family contexts in
addition to the more commonly noted educational impacts (American Psychiatric
Association, 1994). The current study addresses a gap in the literature, which has mostly
focused on the ways ADHD and other comorbid disorders impacts the functioning of
children and adolescents.
Although this study utilized existing medical and assessment records, there was a
wide array of information available and accessible for each individual, including multiple
measures, demographic information, medications, and detailed background information.
The ability to have such in depth information available, even in a study that utilized
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archival records, was helpful in allowing for appropriate analyses to answer the research
questions. Executive functioning, for example, is a term used to encompass various
cognitive processes (Jarratt, 2015) and having multiple measures of executive functioning
allowed for a more in depth look into different skill areas or domains.
Limitations
A number of study limitations must be considered when interpreting the findings.
This study could have benefited from a larger sample. The participants included for
analysis in this study were pulled from archival records from a neuropsychology clinic at a
large academic medical center in the mid-Atlantic United States. Participants were
included after meeting a set of inclusion criteria related to age, other diagnoses, and
availability of test scores needed for analyses. Overall, the study featured data for 129
participants. Preliminary power analyses indicated that with an α of .05, a sample size of
208 participants achieves a power of .95 and that with an α of .05, a sample size of 128
participants achieves a power of .8. A larger sample size would have allowed for more
power in analyses and a broader understanding of the clinical impacts of these disorders
on neuropsychological functioning. Another limitation related to the sample is the
distribution of groups. Of the records reviewed and included in this study, 80 carried a
comorbid diagnosis while 49 received only an ADHD diagnosis. While this is reflective of
the overall prevalence of these disorders co-occurring with one another and the need for
research examining this occurrence, it would have been preferred for the two groups to
mirror each other more closely in size. The sample for this study also featured more
females, which is likely reflective of the higher base rates for anxiety and depression among
women as compared to men (Castanega et al., 2008).
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The current study could also have benefited from more detail surrounding specific
symptoms of anxiety and depression that each participant experienced. Group
membership was based on diagnoses following neuropsychological assessment. This
assessment consisted of a clinical interview, review of patient history, behavioral
observations, and test scores. Utilizing these components, diagnoses were made in the
clinician’s best judgement. Several measures were used to assess ADHD, anxiety, and
depressive symptoms, including the Wender Utah Rating Scales (WURS; (Ward, Wender, &
Reimherr, 1993), Conners Adult ADHD Rating Scale-Self Report: Long Version (CAARS-S:L;
Conners, Erhardt, & Sparrow, 1999), the Beck Anxiety Inventory (BAI; Beck & Steer, 1993),
and the Beck Depression Inventory Second Edition (BDI-II; Beck, Brown, & Steer, 1996).
While the components of the evaluation were sufficient in providing the clinician enough
information to make informed diagnoses, from a research perspective it would have been
beneficial to have more detail regarding types of symptoms experienced and the
individual’s perception of the impact of those symptoms. This would have allowed for
further analyses exploring questions related to the impact of certain types of symptoms
over others (i.e. externalizing vs internalizing). Another useful piece of information would
be the age of diagnosis for ADHD, any anxiety, and/or depressive disorder. This
information would have allowed for further consideration of the longevity and chronicity of
symptoms and impact on neuropsychological functioning.
Implications for Assessment and Intervention
Consistent with other studies of the neuropsychological impact of anxiety,
depression, and ADHD (Jarrett, 2015), the current study found deficits present in those
with ADHD and a co-occurring anxiety or depression disorder. Differences were found in
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areas of functioning depending on the presence of comorbid disorders or the presence of
only ADHD. For assessment purposes, clinicians conducting testing on those with a
diagnosis of ADHD should, as previous research has indicated, expect lower cognitive
processing scores. In addition, clinicians assessing those with a co-occurring anxiety or
depressive disorder should assess for more pronounced deficits in working memory and
measures of visual scanning, sequencing, and psychomotor speed. The current research
findings indicate that the combined impact of these commonly co-occurring groups of
disorders impacts these areas specifically.
In terms of intervention, clinicians can work with their patients to address the more
pronounced deficits that likely exist with the presence of ADHD and an anxiety or
depressive disorder. By further understanding the impact of these disorders on working
memory, clinicians can target this deficit by working with patients on specific strategies.
This may include using visual prompts or reminders, encouraging “chunking” of
information, utilizing visual memory, or making information that they would like to
remember multisensory. Clinicians can help individuals cope with the impact of these
disorders on their daily functioning.
Future Directions
This study highlights the importance of considering the combined impact of dual
diagnosis, specifically when it comes to ADHD and anxiety or depressive disorders.
Working memory is a complex function that plays an integral role in comprehension,
learning, and reasoning (Theiling & Petermann, 2014). Given the important and complex
role of working memory, the deficits found in those with ADHD and a comorbid anxiety or
depression disorder can impact the individuals’ daily functioning, experience of mental
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health symptoms, and treatment efficacy. More research is needed to evaluate the impact
of the deficits found in this study that exist in those with these co-occurring disorders.
Further studies can explore if and how these deficits impact treatment, and how clinicians
can take these deficits into account to alter treatments to be more efficacious.
This study was limited by the smaller sample size and the use of archival data. Due
to the nature of the data, analyses were limited to those utilizing existing test measures.
Future research that uses non-archival data would benefit from more thorough assessment
of symptoms and also from gathering qualitative data from participants about their
experience of their disorders and related deficits. This additional information would allow
for a more in depth look at how these co-occurring disorders present and also how they
impact functioning.
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CHAPTER V
CONCLUSION
The present study examined differences in several areas of neuropsychological test
scores between those diagnosed with ADHD only and those diagnosed with ADHD and a
comorbid anxiety or depressive disorder. With regards to intellectual ability, this study
examined scores for full scale intelligence, general ability, and cognitive proficiency.
Working memory, processing speed, executive functioning, and inattention/impulsivity
scores were also examined. This study examined whether the relationship between ADHD
and the scores in these domains was differentiated by the presence of a comorbid anxiety
or depressive disorder. There were no significant differences between the two groups for
full scale intelligence or general ability. Across both groups, participants had lower
cognitive processing scores when compared to general ability scores. With regards to the
predictive ability of a comorbid diagnosis, only two of the analyses were significant. The
presence of an anxiety or depressive disorder predicted the relationship between ADHD
and working memory and a measure of visual scanning, sequencing, and psychomotor
speed (Trailmaking A). In other words, scores on these two outcome variables
differentiated participants who had a co-occurring anxiety or depression diagnosis from
those with only ADHD. Future research would benefit from a larger sample size and, if
utilizing non-archival data, more specific measures that would assess specific symptoms
experienced, severity, and gather qualitative data about the individuals’ experience of these
co-occurring disorders.
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